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Endothelial dysfunction has been defined as an “integrated risk factor”, and sev-
eral gender difference have been reported in endothelial function. Several evidences 
suggest that endothelial progenitor cells (EPCs) are an important endogenous sys-
tem that maintains integrity and vascular homeostasis. Their function is regulated by 
estrogens and estrogen receptors (ERs), but the effect of estrogenic compounds such 
as bisphenol A (BPA) and (R,R)-5,11-diethyl-5,6,11,12-tetrahydro-2,8-chrysenediol 
(THC) on human EPCs is unknown. BPA is used in plastic industry and BPA expo-
sure is associated to abnormalities such as obesity, diabetes, disorders of the repro-
ductive and immune systems, to endothelial dysfunction, and oxidative stress. This 
endocrine disruptor binds to ERα and ERβ with higher affinity for ERβ. THC is a 
specific agonist of ERα with a stronger ERβ antagonist activity. Therefore, the pre-
sent work aimed to analyze if BPA and THC influence in a sex-specific manner the 
migration of human EPCs, an essential process in endothelial regeneration after vas-
cular injury. EPCs were isolated from healthy adult men and women aged between 
18 and 30 years, using a magnetic positive selection with the CD34 MicroBeads, a 
well-established marker of human progenitor cells. EPCs were also characterized for 
acetylated LDL Dil- (acLDL) and isothiocyanate (FITC)-conjugated with Ulex euro-
paeus agglutinin I (lectin) uptake. The expression of ERα and ERβ was analysed by 
Western Blotting, while the migration assay was performed with the transwell chem-
otaxis assay. Male and female EPCs expressed both classical ERs: ERα was higher, 
but not significantly, in female cells, while ERβ was similarly expressed in both sexes. 
Male and female EPCs did not differ in basal migration. 17-β-estradiol (10-9 M e 10-10 
M) significantly inhibited migration in female EPCs but not in male ones. Moreover, 
both 10-5 M THC and BPA (10-8 M) were able to bock migration only in female cells. 
Considering that BPA has a ERα and a prevalent ERβ agonist activity while THC has 
ERα agonistic activity and a prevalent ERβ antagonist activity, our data show that 
the effect on migration observed in female EPCs is mediated by ERα. Our data dem-
onstrate that estrogenic compound have a sexual divergent effect on human EPCs, 
improving our knowledge on the gender differences observed in the pathophysiology 
of endothelial function.
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